0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Each month JAMA Oncology keeps you up-to-date with the most important advances in the field. Subscribe/Learn More

Current Highlights

Follow Us

Original Investigation | June 23, 2016 FREE ONLINE FIRST

Candesartan for Preventing Trastuzumab-Related Cardiotoxic Effects in Breast Cancer

This randomized clinical trial compares candesartan vs placebo for preventing LVEF reduction in patients with breast cancer treated with trastuzumab.
Invited Commentary

Review | June 23, 2016 ONLINE FIRST

Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes

This review examines the median percentage of patients with breast cancer with no, intermediate, or high levels of tumor-infiltrating lymphocytes and assesses variations in lymphocytic cell subsets across breast cancer subtypes.

Original Investigation | June 16, 2016 ONLINE FIRST

Extent of Resection and Survival in Glioblastoma

This meta-analysis summarizes published estimates of association between extent of glioblastoma multiforme resection and overall and progression-free survival.

Review | June 16, 2016 ONLINE FIRST

Biomarkers for PD-1/PD-L1 Inhibitor Use in Non–Small-Cell Lung Cancer

This review summarizes available and candidate biomarkers for the selection of patients who might benefit from the use of PD-1/PD-L1 inhibitors for the treatment of non–small-cell lung cancer.

Editorial | June 15, 2016 ONLINE FIRST

Colorectal Cancer Screening

This editorial reviews the the US Preventive Services Task Force June 2016 recommendation statement on colorectal cancer screening.
US Preventive Services Task Force Recommendation

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Interview with Razelle Kurzrock, MD, author of Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis

audio player

RELATED ARTICLE:

Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms A Meta-analysis

All Author Interviews >

Author Readings
Author photo

audio player

RELATED ARTICLE:


Latest Quiz

All Quizzes >

A Seemingly Solitary Bone Lesion

A white woman in her 60s with a medical history of multiple joint replacements related to osteoarthritis presented with left leg pain; a plain radiograph of the left femur showed a 15-cm area of moderate destruction in the proximal femoral shaft extending distally from the level of the lesser trochanter.

What is your diagnosis?

Image of JAMA forum logo

Physician Jobs